Next Article in Journal
Tissue Engineering of Cartilage; Can Cannabinoids Help?
Next Article in Special Issue
Comments on the Eslicarbazepine Acetate Section of the Article ‘Therapeutic Drug Monitoring of the Newer Anti-Epilepsy Medications’
Previous Article in Journal
Mechanisms of Broad-Spectrum Antiemetic Efficacy of Cannabinoids against Chemotherapy-Induced Acute and Delayed Vomiting
Previous Article in Special Issue
Update on the Genetic Polymorphisms of Drug-Metabolizing Enzymes in Antiepileptic Drug Therapy
Open AccessReview

The Art of Managing Conversions between Antiepileptic Drugs: Maximizing Patient Tolerability and Quality of Life

Department of Neurology, Mayo Clinic, 200 First Street Southwest, Rochester, MN 55905, USA
Pharmaceuticals 2010, 3(9), 2956-2969; https://doi.org/10.3390/ph3092956
Received: 29 July 2010 / Revised: 12 August 2010 / Accepted: 2 September 2010 / Published: 6 September 2010
(This article belongs to the Special Issue Antiepileptic Drugs)
Conversion between anti-epilectic drugs (AEDs) is frequently necessary in epilepsy care, exposing patients to a risk of incurring adverse effects and reduced quality of life. Little practical guidance is available to practitioners to guide conversions between AED monotherapies, or in adding a new adjunctive AED into a polytherapy regimen. This article reviews the impact of adverse effects of AEDs on quality of life in epilepsy patients, then reviews several important patient-related factors such as age, gender, medical and psychiatric co-morbidities, and co-medications that must be considered when selecting AEDs and ensuring tolerable and safe AED conversions. Practical strategies for transitional polytherapy AED conversion are then considered in different commonly encountered clinical scenarios in newly diagnosed and refractory epilepsy care, including inadequate seizure control, intolerable adverse effects, or idiosyncratic safety hazards. Successful conversion between AEDs requires regular monitoring for patient-reported adverse effects and appropriately reactive adjustment of AED therapy to maximize patient quality of life. View Full-Text
Keywords: epilepsy; antiepileptic drugs; conversion; monotherapy; polytherapy; quality of life epilepsy; antiepileptic drugs; conversion; monotherapy; polytherapy; quality of life
MDPI and ACS Style

Louis, E.K.S. The Art of Managing Conversions between Antiepileptic Drugs: Maximizing Patient Tolerability and Quality of Life. Pharmaceuticals 2010, 3, 2956-2969.

Show more citation formats Show less citations formats

Article Access Map by Country/Region

1
Only visits after 24 November 2015 are recorded.
Back to TopTop